| |
Kuna, S. t., Borradiale, K. E., Sanders, M. H., Millman, R. P., Zammit, G. K., Wadden, T. A., Kelley, D. E., Wing, R. R., Pi-Sunyer, F. X., & Foster, G. (2009). Symptom questionnaires do not predict the presence or severity of obstructive sleep apnea in obese patients with type 2 diabetes. Sleep, 32, Abstract Supplement, A170.
Quan, S., Zammit, G., Malhotra, A., Wyatt, J., Edinger, J., & Krystal, A. (2009). The relationship between MSLT nap onset latency and the effect of vestibular stimulation on transient insomnia. Sleep, 32, Abstract Supplement, A288.
Zammit, G., Lankford, A., Rosenberg, R., Scharf, M., Moore, P., Yen, M., Edinger, J., & Krystal, A. (2009). The effect of vestibular stimulation on transient insomnia induced by a five-hour phase advance. Sleep, 32, Abstract Supplement, A289.
Loboda A, Kraft WK, Fine B, Joseph J, Nebozhyn M, Zhang C, He Y, Yang X, Wright C, Morris M, Chalikonda I, Ferguson M, Emilsson V, Leonardson A, Lamb J, Dai H, Schadt E, Greenberg H E and Lum PY (2009) Diurnal Variation of the Human Adipose Transcriptome and the Link to Metabolic Disease, BMC Medical Genomics 2009, 2:7.
Taub, L.F., Lund S., Freeman, J., Anwar, S., Segal, O. Differences in Sleep Quality and
Daytime Sleepiness Before and After CPAP Use – accepted for publication in Sleep, 2009,
presented at the AASM meeting, Seattle, June, 2009.
Khan, Z., Hyatt, S., Bachan, M., Jones, D., Ghassibi, J., Lund, S., Freeman, J. Oxygen
saturation in obstructive sleep apnea (OSA) and normal controls: Comparison between REM
versus NREM and phasic REM (PREM) versus tonic REM (TREM) – accepted for
publication in Sleep, 2009 and presented at the AASM meeting, Seattle, June, 2009.
Lund, S. and Freeman, J. Polysomnography. In: Sleep Apnea and Snoring – Surgical and Non-Surgical Therapy, Friedman, M. (ed.). Saunders/Elsevier, 2009, 22 – 32.
Taub, L.F., Lund S., Freeman, J., Anwar, S., Segal, O. Differences in Sleep Quality and Daytime Sleepiness Before and After CPAP Use – accepted for publication in Sleep, 2009 and to be presented at the AASM meeting, Seattle, June, 2009.
Khan, Z., Hyatt, S., Bachan, M., Jones, D., Ghassibi, J., Lund, S., Freeman, J. Oxygen saturation in obstructive sleep apnea (OSA) and normal controls: Comparison between REM versus NREM and phasic REM (PREM) versus tonic REM (TREM) – accepted for publication in Sleep, 2009 and to be presented at the AASM meeting, Seattle, June, 2009.
Gangwisch J.E., Heymsfield S.B., Boden-Albala B., Buijs R.M., Kreier F., Opler M.G., Pickering T.G., DPhil; Rundle A.G., Zammit G.K., Malaspina D. Sleep Duration Associated with Mortality in Elderly, but not Middle-Aged, Adults in a Large US Sample. SLEEP. Vol. 31, No. 8: 1087-1096. Aug. 2008.
Zammit G.K., Wang-Weigand S., Peng X. Use pf computerized dynamic posturography to assess balance in older adults after night time awakenings using zolpidem as a reference. BMC Geriatrics 8:15. July 15 2008.
Erman M.K, Zammit G.K., Rubens R, Schaefer K, Wessel T, Amato D, Caron J, Walsh J.K. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. J Clin Sleep Med. 2008 Jun 15;4(3):229-34.
Zammit G.K. Antidepressants and Insomnia. Primary Psychiatry. Vol 15, No.5: 61-69. 2008.
Zammit G.K. Zolpidem Extended-Release: Therapy for Sleep Induction and Sleep Maintenance Difficulties. Expert Opin. Drug Metab. Toxicol. Vol 4, No.3: 325-331. 2008.
Zammit, G. K., Accomando, W., Sprenger, K., & Aneiro, L. (2008). Rapid sleep onset in patients with chronic insomnia with no tolerance or rebound insomnia after 14 days of treatment with adipiplon. Sleep, 31, Abstract Supplement, A245.
Zammit, G. K. Ding, Y., & McCoy, A. (2008). The use of a virtual private network (VPN) to manage global clinical trials: analysis of cost and performance. Presented at the annual meeting of the Drug Information Association, June 24, Boston, MA.
Coelho-D’Costa, V., Tsegaye, A., Freeman, J., Lund, S. PAP (Positive Airway Pressure)
titration via split-night polysomnography (SNP) vs full night PAP titration (FNT) in pts
with OSA – accepted for publication in Sleep, 2008, 31, A0469 and presented at the AASM
meeting, Baltimore, Maryland, June, 2008.
Kaul,V., Rampersaud, R., Heddings, L., Freeman, J., Lund, S. Affective and Cognitive
Symptoms in REM-Related Obstructive Sleep Apnea (ROSA) vs NREM-Related OSA
(NOSA) – accepted for publication in Sleep, 2008, 31, A0470 and presented at the AASM
meeting, Baltimore, Maryland, June, 2008.
Iwamoto M, Wenning LA, Petry AS, Laethem M. De Smet M. Kost JT, Breidinger SA. Mangin EC. Azrolan N. Greenberg HE, Haazen W. Stone JA. Gottesdiener KM, Wagner JA. (2008) Minimal Effects of Ritonavir and Efavirenz on the Pharmacokinetics of Raltegravir, Antimicrob. Agents Chemother. 2008; 52: 4338-4343.
Lai E, Wenning LA, Crumley TM, Liu F, de Hoon JN, Van Hecken A, Depre M, Hilliard D, Greenberg HE, O’Neill G, Metters K, Gottesdiener KG, Wagner JA. (2008) Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist, Clinical Pharmacology & Therapeutics 2008; 83(6): 840-847.
Yadgarov, D., Liang, L., Freeman, J., Lund, S. Using Cyclic Alternating Pattern as a
predictor of an optimal CPAP titration – accepted for publication in Sleep, 2008, 31, A0491
and presented at the AASM meeting, Baltimore, Maryland, June, 2008.
Zammit G.K. Ramelteon: A Novel Hypnotic Indicated for the Treatment of Insomnia. Psychiatry. Vol 4, No. 9. 36-42. September 2007
Zammit G.K. Balance Assessment After Nighttime Awakenings in Healthy Older Adults With and Without Zolpidem Administration. Presented at Society For Neuroscience, 37th Annual Meeting. November 2007
Zammit G.K. The Prevalence, Morbidities, and Treatments of Insomnia. Neurological Disorders: Drug Targets. Vol. 6: 3-16.
Erman M, Krystal A, Zammit G.K., Soubrane C, Roth T. Long-term Efficacy of Zolpidem Extended-Release in the Treatment of Sleep Maintenance and Sleep Onset Insomnia with Improvements in Next-Day Functioning. SLEEP. Vol. 30, Abstract Suppl: A241.
Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, Rundle AG, Zammit G.K., Malaspina D. Sleep Duration as a Risk Factor for Diabetes Incidence in a Large US Sample. SLEEP. Vol. 20, No. 12.
Skopicki HA., Sackner-Bernstein J. Teaching Failure: What Fellows Want To Know. American College of Cardiology.
Sackner-Bernstein J., Hirshkowitz M, Schmidt-Nowara W., Chervin RD, Richter RW. Modafinil Does Not Affect Cardiovascular Safety in Patients with Preexisting Hypertension and Excessive Sleepiness-Associated Obstructive Sleep Apnea. American Thoracic Society.
Zammit, G. K. 2007). The prevalence, morbidities, and treatments of insomnia. CNS Neurological Disorders: Drug Targets, 6, 3 – 16.
Gangwisch, J. E., Heymsfield, S. B., Boden-Albala, B., Buijs, R. M., Kreier, F., Pickering, T. G., Rundle, A. G., Zammit, G. K., Malaspina, D. (2007). Sleep duration as a risk factor for diabetes incidence in a large US sample, Sleep, 30, 1667 – 1673.
Zammit, G. K. (2007). Ramelteon: A novel hypnotic indicated for the treatment of insomnia. Psychiatry, 4, 36 – 42.
Roth T., Zammit G.K., Scharf M., Farber R. (2007). Efficacy and Safety of As-Needed, Post Bedtime Dosing with Indiplon in Insomnia Patients with Chronic Difficulty Maintaining Sleep. Sleep; 30(12):1731-1738.
Gangwisch, J. E., Heymsfied, S. B., Boden-Albala, B., Buijs, R. M., Kreier, F., Pckering, T. G., Rundle, A. G., Zammit, G. K., Malaspina, D. (in preparation). Sleep duration associated with mortality in elderly, but not middle-aged adults in a large U.S. sample” or “Age differences in the association between sleep duration and mortality in a large U.S. sample.
Najib, J. & Zammit, G. K. (in preparation). Eszopiclone: Efficacy and Safety. In Pandi-Perumal, Verster, Monti, Lader, & Langer (Eds.), Sleep Disorders: Diagnosis and Therapeutics.
Greenblatt, D., Harmatz, J., Zammit, G.K., Accomando, W., Sprenger, K., & Aneiro, L. (2007). Pharmacokinetic-Pharmacodynamic Effects of NG2-73, A Novel GABA(A) Agonist and Zolpidem. Sleep, 30, Abstract Supplement, A40.
Zammit, G., Rice, K., Accomando, W., Sprenger, K., & Aneiro, L. (2007). Effects of NG2-73 on Sleep Onset, Quality and Next Day Function in a Transient Insomnia Study. Sleep, 30, Abstract Supplement, A239.
Erman, M., Krystal, A., Zammit, G., Soubrane, C., & Roth, T. (2007). Long-term efficacy of zolpidem extended-release in the treatment of sleep maintenance and sleep onset insomnia with improvements in next-day functioning. Sleep, 30, Abstract Supplement, A241.
Erman, M., Krystal, A., Zammit, G., Soubrane, C., & Roth, T. (2007). No evidence of rebound insomnia in patients with chronic insomnia treated with zolpidem extended-release 12.5 mg administered “as needed” 3 – 7 nights/week for 6 months. Sleep, 30, Abstract Supplement, A241.
Wang-Weigand, S., Zammit, G., & Peng, X. (2007). Effect of Ramelteon on middle-of-the-night balance, mobility, and memory performance in older adults. Sleep, 30, Abstract Supplement, A244.
Ahmad, M. Caffrey, P., Freeman, J., Lund, S. Rapid Eye Movement (REM) Density
and Eye Movement Distribution in Patients Taking Selective Serotonin Reuptake
Inhibitors (SSRI) – Sleep, 2007, 30, A337 and presented at the AASM meeting,
Minneapolis, Minnesota, June, 2007.
Bhola, A., Mouskourie, E., Freeman, J., Lund, S. Gender and age differences in the
initial acceptability of continuous positive airway pressure (CPAP) in obstructive
sleep apnea – Sleep, 2007, 30, A200 and presented at the AASM meeting,
Minneapolis, Minnesota, June, 2007.
Verma, N., Konstantinova, N., Freeman, J., Lund, S. Comparison of subjective and
objective assessment of sleep onset (SO) on the multiple sleep latency test (MSLT)
using standard and microsleep criteria – Sleep, 2007, 30, A353 and presented at the
AASM meeting, Minneapolis, Minnesota, June, 2007.
Oropello, J., Ostrovskaya, M., Freeman, J., Lund, S. Do Mallampati scores correlate
with optimal continuous positive airway pressure (CPAP) determined by CPAP
titration during full-night polysomnography? – Sleep, 2007, 30, A185 and presented
at the AASM meeting, Minneapolis, Minnesota, June, 2007.
Kaul, V., Rampersaud, R., Heddings, L., Freeman, J., Lund, S. Affective and
Cognitive symptoms in NREM versus REM obstructive sleep apnea – presented at
the North East Sleep Society, 21st Annual Meeting, March, 2007
Erman M, Seiden D, Zammit G.K., Sainati S, Zhang J. An Efficacy, Safety, and Dose-Response Study of Ramelteon in Patients with Chronic Primary Insomnia. Sleep Medicine. Vol. 7: 17-24.
Walsh JK, Zammit G.K., Schweitzer PK, Ondrasik J, Roth T. Tiagabine Enhances Slow Wave Sleep and Sleep Maintenance in Primary Insomnia. Sleep Medicine. Vol. 7: 155-161.
Zammit G.K. HD-16: Measuring Quality of Life in Insomnia. Insom. Vol. 7: 33-35.
Ghassibi J, Freeman J, Zammit G.K., Ghassibi M. Correlation Between Daytime Functioning Score and Severity of Obstructive Sleep Apnea (OSA). SLEEP. Vol. 29, Asbtract: A157.
Zammit G.K., Schwartz H, Roth T, Wang-Weigand S, Zhang J. Effect of Ramelteon, a Selective MT1/MT2 Receptor Agonist, in a First-Night-Effect Model of Transient Insomnia. SLEEP. Vol. 29, Asbtract: A238.
Sackner-Bernstein J., Skopicki HA, Aaronson KD; Arthur Feldman (Ed.). Natriuretic Peptides for the Treatment of Acutely Deompensated Heart Failure. Heart Failure: Pharmacologic Management.
Sackner-Bernstein J., Biederman J, Jiang JG, Earl CQ. Cardiovascular Safety of Modafinil-ADHD in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. American Association of Pediatrics.
Greenblatt D, Legangneux E, Harmatz J, Weinling E, Freeman J, Rice K, Zammit G. Dynamics and Kinetics of a Modified-Release Formulation of Zolpidem: Comparison With Immediate-Release Standard Zolpidem and Placebo. Journal of Clinical Pharmacology 2006;46:1469-1480.
Hauptman PJ, Pressler SJ, Sackner-Bernstein J, Ordronneau P, Udelson JE; CASPER Investigators. Rationale and Design of CASPER: Compliance and Quality of Life Study Comparing Once-Daily Carvedilol CR and Twice-Daily Carvedilol IR in Patients with Heart Failure. Am J Cardiol. 2006 Oct 2;98(7A):60-6. Epub 2006 Aug 28.
Aaronson KD, Sackner-Bernstein J. Risk of death associated with nesiritide in patients with acutely decompensated heart failure. JAMA. 2006 Sep 27;296(12):1465-6.
Malli, D., Adachi, M., Ghassibi, J., V., Freeman, J., Lund, S. Correlation between body mass index, apnea/hypopnea index and CPAP pressure requirements in patients with obstructive sleep apnea – presented at the North East Sleep Society, 20th Annual Meeting, March 17, 2006.
Coelho-D’Costa, V., Tsegaye, A. Freeman, J., Lund, S. Comparison of positive airway pressure (PAP) titration via split-night study polysomnography vs full night PAP titration in patients with obstructive sleep apnea - presented at the North East Sleep Society, 20th Annual Meeting, March 17, 2006.
Damian, J., Coelho-D’Costa, V., Narasimhan, M., Freeman, J., Lund, S. Referral patterns from various types of subspecialists to a sleep center & their accuracy in predicting the diagnosis of obstructive sleep apnea” – presented at the North East Sleep Society, 20th Annual Meeting, March 17, 2006.
Zammit, G. K. Gold Standard Celebrates Silver Anniversary. Advance for Managers of Respiratory Care. 39-41. November 2006.
McCall WV, Erman M, Krystal AD., Rosenberg R., Scharf M., Zammit, GK., Wessel T. A polysomnography study of eszopiclone in elderly patients with insomnia. Current Medical Research and Opinion, Vol. 22, No. 9, 2006, 1633-1642.
Zammit, G. K., Corser, B., Doghramji, K., Fry , J. M. , Krystal , A., James , S., & Mangano, R. M. (2006). Sleep and Residual Sedation After Administration of Zaleplon, Zolpidem, and Placebo During Experimental Middle-of-the-Night Awakening. Journal of Clinical Sleep Medicine, 2006 Nov 4. Vol. 2. 417-423.
Zammit, G. K. (2006). Indiplon: A single compound in two formulations for the treatment of insomnia. Future Neurology, 1, 259 – 268.
Gangswisch, J. E. , Heymsfield, S. B. , Boden-Albala, B., Buijs, R. M., Kreier, F., Pickering, T. G., Rundle, A. G., Zammit, G. K., Malaspina, D. (2006). Short sleep duration as a risk factor for hypertension. Analysis of the First National Health and Nutrition Examination Survey. Hypertension, 47, 833 - 839.
|
